James Allison’s aim is true. His work led to the development of cancer immunotherapies known as “checkpoint inhibitors,” and he will deliver the next Flexner Discovery Lecture on Thursday, March 8.
James Allison’s aim is true. His work led to the development of cancer immunotherapies known as “checkpoint inhibitors,” and he will deliver the next Flexner Discovery Lecture on Thursday, March 8.